Aclarion, Inc.

Contributing Author

Recent Articles by Aclarion, Inc.

Dec-04	Aclarion Announces Publication of Nociscan Article in Special Pain Issue of the International Journal of Spine Surgery (IJSS) ACON GlobeNewswire
Dec-02	Aclarion Appoints Jason Brosniak as Commercial Director to Drive Adoption and Market Expansion in the Eastern U.S. ACON GlobeNewswire
Nov-05	Aclarion Appoints Dan Isherwood as UK Commercial Director to Drive Adoption and Market Expansion ACON GlobeNewswire
Oct-22	Aclarion Wins "Rising Star" at 2025 Digital Health Hub Foundation: Digital Health Awards at HLTH ACON GlobeNewswire
Oct-14	Aclarion Provides Corporate Update Highlighting Market Expansion as CLARITY Trial Advances Toward Key Data Catalyst ACON GlobeNewswire
Oct-13	Aclarion Announces Use of MR Spectroscopy for identifying Biomarkers of Discogenic Pain highlighted at Global Neuroscience Conference ACON GlobeNewswire
Oct-07	Aclarion Honored as Finalist for the 2025 Digital Health Hub Foundation: Digital Health Awards at HLTH ACON GlobeNewswire
Oct-01	Aclarion Presents at LSI Europe '25 Highlighting Nociscan Technology and Key Value Drivers ACON GlobeNewswire
Sep-25	First Patients Enrolled at UHealth - University of Miami in Aclarion's Pivotal CLARITY Trial ACON GlobeNewswire
Sep-03	Aclarion Appoints Greg Gould as Chief Financial Officer ACON GlobeNewswire
Aug-05	Aclarion Provides Corporate Update Highlighting Scan Volume Growth and Key Upcoming Catalysts ACON GlobeNewswire
Jul-07	Aclarion, Inc. Announces Adjournment of Annual Meeting of Stockholders ACON GlobeNewswire
Jun-25	First Patient Enrolled in Aclarion's Groundbreaking CLARITY Trial ACON GlobeNewswire
Jun-24	Aclarion to Present NOCISCAN Technology at Leading Spine Innovation Forum ACON GlobeNewswire
Jun-10	Aclarion Adds UHealth, University of Miami Miller School of Medicine as CLARITY Trial Site ACON GlobeNewswire
May-20	Aclarion Announces Addition of Keck Medical Center of USC as CLARITY Trial Site ACON GlobeNewswire
May-12	Aclarion Announces Texas Back Institute as New CLARITY Trial Site ACON GlobeNewswire
May-05	Aclarion Welcomes Advocate Health as CLARITY Trial Site ACON GlobeNewswire

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2025 Finviz.com. All Rights Reserved.